- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: KY1044 and atezolizumab
Total 271753 results
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingMelanoma | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Neoplasms by Site | Cancer | Colorectal Neoplasms | Endometrial Neoplasms | Malignant Neoplasm | MalignancyUnited Kingdom
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
AIO-Studien-gGmbHRoche Pharma AG; Immodulon Therapeutics LtdRecruiting
-
Harpoon TherapeuticsRecruitingNeuroendocrine Carcinoma | Small-Cell Lung CancerUnited States
-
Lawrence FongNational Cancer Institute (NCI); Genentech, Inc.; The V Foundation; Conquer Cancer... and other collaboratorsCompleted
-
SynlogicIQVIA BiotechTerminatedLymphoma | Metastatic Solid NeoplasmUnited States
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Clinical Trial Unit Ente Ospedaliero... and other collaboratorsActive, not recruitingNSCLC Stage IVSwitzerland
-
European Organisation for Research and Treatment...Hoffmann-La RocheTerminatedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeSpain, Switzerland
-
Liza Villaruz, MDGenentech, Inc.CompletedAdvanced Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Resectable Lung Non-Small Cell Carcinoma | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
BayerActive, not recruitingUrothelial CarcinomaUnited States, Korea, Republic of, Japan, Germany, Italy, Spain, Austria, France
-
University Hospital, EssenCompletedWindow of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN (PIONEER)Squamous Cell Carcinoma of Head and NeckGermany
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
Peter MacCallum Cancer Centre, AustraliaTrans Tasman Radiation Oncology GroupCompleted
-
University of Kansas Medical CenterNot yet recruiting
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.; Oncoceutics, Inc.RecruitingMetastasis | Endometrial CancerUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingIntrahepatic CholangiocarcinomaGermany
-
Deepak KilariGenentech, Inc.; Medical College of Wisconsin; ExelixisRecruitingBladder CancerUnited States
-
Genentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, France, Serbia
-
Washington University School of MedicineGenentech, Inc.Terminated
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Chugai PharmaceuticalRecruitingSolid TumorUnited States, Japan
-
Hoffmann-La RocheRecruitingMuscle-invasive Bladder CancerBelgium, Korea, Republic of, Japan, Brazil, China, United States, Singapore, France, United Kingdom, Canada, Greece, Italy, Spain, Turkey, Russian Federation, Ukraine, Israel, Czechia, Colombia, Hong Kong, Argentina, Germany, Ireland, Polan... and more
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingLocally Advanced Cervical CancerFrance
-
Eikon TherapeuticsSeven and Eight Biopharmaceuticals IncActive, not recruitingTumor, SolidUnited States
-
Galecto Biotech ABHoffmann-La Roche; Linical Europe GmbHActive, not recruitingNon-Small Cell Lung CancerSpain, Poland, France
-
Hoffmann-La RocheCompletedBladder CancerUnited States, Spain, United Kingdom, Canada, France, Germany, Italy, Netherlands
-
Hoffmann-La RocheCompletedSolid TumorsKorea, Republic of, Spain, Denmark, France, United Kingdom
-
Hoffmann-La RocheActive, not recruitingSmall Cell Lung Cancer | Hepatocellular Carcinoma | Non-Small Cell Lung Cancer | Urothelial CarcinomaHungary, United Kingdom, Belgium, Croatia, France, Italy, Spain, United Arab Emirates, Argentina, Bulgaria, Poland, Philippines, Serbia, Netherlands, Romania, Colombia, Austria, Russian Federation, Singapore, Estonia, Egypt, India, ... and more
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Belgium, Turkey, United Kingdom, Germany, Poland, Canada, France, Thailand, Italy, Sweden
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States, Canada
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Hoffmann-La RocheActive, not recruitingSquamous Cell Carcinoma of Head and NeckUnited States, Korea, Republic of, United Kingdom, Czechia, New Zealand, France, Spain, Greece, Thailand, Taiwan, Hungary, Italy, Poland
-
Hoffmann-La RocheActive, not recruitingNon-Small Cell Lung CancerHungary, Korea, Republic of, Australia, Spain, China, Denmark, Italy, Germany, Mexico, Poland, United States, Brazil, Peru, Thailand, Serbia, Switzerland, Japan, Turkey, Netherlands, Austria, Taiwan, Russian Federation, Ukraine, Greece
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingNon-small Cell Lung Cancer | Malignant Pleural MesotheliomaSwitzerland
-
University Hospital, BrestRoche Farma, S.A; Pierre Fabre Medicament; Groupe Français de Pneumo-CancérologieCompleted
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Hoffmann-La RocheRecruitingUrothelial CancerKorea, Republic of, United States, Brazil, China, France, Germany, Mexico, Poland, Denmark, Italy, Turkey, Australia, Greece, Spain, United Kingdom
-
Ronald BuckanovichGenentech, Inc.RecruitingPARP Inhibitor | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Hedgehog InhibitorUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
Hoffmann-La RocheExelixis; ChugaiActive, not recruitingCarcinoma, Renal CellUnited States, Korea, Republic of, France, Denmark, Italy, Poland, Spain, Japan, Canada, Argentina, United Kingdom, Russian Federation, Australia, Germany, Greece
-
Institut für Klinische Krebsforschung IKF GmbH...Thoraxklinik-Heidelberg gGmbHActive, not recruitingThoracic Radiotherapy | Small Cell Lung Cancer Extensive StageGermany, Austria
-
Gynecologic Oncology AssociatesMerck Sharp & Dohme LLCTerminatedOvarian NeoplasmsUnited States
-
Janssen-Cilag International NVCompleted
-
Fundacion Espanola para la Curacion de la Leucemia...Pfizer; Roche Farma, S.ATerminatedChronic Phase-Chronic Myeloid LeukemiaSpain
-
Sun Yat-sen UniversityCompletedHepatocellular CarcinomaChina